FDA product code JNS: Stannous Chloride - Hydrazine, Phospholipids
JNS is the FDA product code for stannous chloride - hydrazine, phospholipids. It is a Class I device, regulated under 21 CFR 862.1575 and reviewed by the Clinical Chemistry panel. Devices under JNS reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Stannous Chloride - Hydrazine, Phospholipids |
| Device class | Class I |
| Regulation | 21 CFR 862.1575 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for JNS devices
openFDA lists no recalls for product code JNS.
Frequently asked questions
What is FDA product code JNS?
JNS is the FDA product code for stannous chloride - hydrazine, phospholipids. It is a Class I device, regulated under 21 CFR 862.1575 and reviewed by the Clinical Chemistry panel.
What device class is JNS?
Class I, regulation 21 CFR 862.1575. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code JNS
- Run a recall and safety report across every JNS manufacturer
- Watch product code JNS for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times